Advances in cancer treatment mean that more people than ever are surviving the disease. However, some of the most effective ...
A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...
Pharmaceutical Technology on MSN
Targeted therapies to join chemo as oncology treatment backbone
Experts agree that combination approaches, which may or may not include chemotherapy, will drive improved patient outcomes in oncology.
The prescribed dosage for ondansetron may vary depending on a person’s individual treatment plan. Factors such as your medical history and other medications you take may also affect your dosage of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results